Navigation Links
Orexigen(R) Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk
Date:10/24/2009

SAN DIEGO, Oct. 24 /PRNewswire-FirstCall/ -- Orexigen® ( )Therapeutics, Inc (Nasdaq: OREX) today announced new data from the COR-I, COR-II and COR-Diabetes trials for Contrave® (bupropion SR/ naltrexone SR) to expand on top-line results announced in July. Contrave is the first of the Company's two late stage candidates for the treatment of obesity. These data were presented during a panel discussion at the 27th Annual Scientific Meeting of The Obesity Society.

These new data show that after completing 56 weeks of therapy with Contrave32:

  • Approximately 34-48% of patients lost at least 10% of their baseline body weight and approximately 17-23% lost at least 15%;
  • Obese patients classified as higher risk for developing cardiovascular disease and diabetes demonstrated significant improvement in markers of cardiometabolic risk such as waist circumference, HDL, and triglycerides;
  • Patients with type 2 diabetes taking Contrave who began the trial with a hemoglobin A1c (HbA1c) level greater than 8% saw a mean HbA1c reduction of 1.1%, which was highly statistically significant compared to placebo;
  • Patients reported an increased ability to control their eating and resist food cravings; and
  • There was no evidence of increased abuse liability.

"These data show that Contrave provides obese patients with meaningful reduction in weight and improvement in important markers of cardiometabolic risk, with even greater improvement seen in patients at higher risk," said Dennis Kim, M.D., Senior Vice President of Medical Affairs. "Results also illustrate the robust glycemic benefit of Contrave in patients who have poorly controlled diabetes, as defined by a hemoglobin A1C level greater than 8.0. These patients experienced a clinically meaningful A1C reduction of 1.1% fro
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Orexigen(R) Therapeutics Announces Webcast of Third Quarter Financial Results on November 6, 2008
2. Orexigen(R) Therapeutics to Speak at J.P. Morgan Healthcare Conference
3. Orexigen(R) Therapeutics Names Patrick Mahaffy to Board of Directors
4. Orexigen(R) Therapeutics Names Michael Narachi, 24-Year Biopharmaceutical Veteran, New President and Chief Executive Officer
5. Orexigen(R) Therapeutics Announces In-Licensing of Key Patents to Further Strengthen its Intellectual Property Estate for Contrave(R)
6. Orexigen(R) Therapeutics Announces Proposed Public Offering of Common Stock
7. Orexigen(R) Therapeutics Prices Public Offering of Common Stock
8. Orexigen(R) Therapeutics Announces Second Quarter 2009 Financial Results
9. Orexigen(R) Therapeutics Phase 2b Trial for Empatic(TM) Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus Comparators in Obese Patients
10. Prime Therapeutics Receives TIPPS Certification
11. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... With Mother's Day, graduation and grilling ... country's leading organic vegetable brands, knows exactly what's ... country. What to eat? There’s no need to ... hours browsing Pinterest – Josie's Organics added fresh, ... , The new recipes are sophisticated and easy ...
(Date:5/5/2015)... Tulsa, Oklahoma (PRWEB) May 05, 2015 ... have the money for a fitness membership? Don’t know ... all of these obstacles in order to help members ... greatest life. Live Streaming Fitness, an educational, caused-based wellness ... that offers live streaming fitness classes led by certified ...
(Date:5/5/2015)... NY (PRWEB) May 05, 2015 Sheltering ... and honored Walt “Clyde” Frazier and Cravath, Swaine & ... New York’s highest-need communities. The event was co-chaired by ... Kupferberg. , “The Next Chapter” highlighted Sheltering Arms’ significant ... which was unveiled in February 2015. Formerly Episcopal Social ...
(Date:5/5/2015)... OH (PRWEB) May 05, 2015 Buckeye ... as the new CEO and plan president of Buckeye ... organizations, assumes the position immediately. , Hill has more ... Midwest to the Pacific Northwest, from managed care to ... as president and CEO of HealthPlus of Michigan, a ...
(Date:5/5/2015)... Burnie, MD (PRWEB) May 05, 2015 ... in an upcoming episode of Innovations with Ed Begley ... and show times TBA. , This segment will focus ... home testing. Viewers will learn about their AccuSom® home ... sleep test that provides continuous patient support and next-day ...
Breaking Medicine News(10 mins):Health News:Josie's Organics Kicks Off Mother's Day, Graduation and Grilling Season with New, Easy-to-Follow, Convenient Recipes 2Health News:Josie's Organics Kicks Off Mother's Day, Graduation and Grilling Season with New, Easy-to-Follow, Convenient Recipes 3Health News:Josie's Organics Kicks Off Mother's Day, Graduation and Grilling Season with New, Easy-to-Follow, Convenient Recipes 4Health News:Live Streaming Fitness Creates Industry Shift by Bringing Fitness, Nutrition and Cooking Classes to Smart Devices 2Health News:Live Streaming Fitness Creates Industry Shift by Bringing Fitness, Nutrition and Cooking Classes to Smart Devices 3Health News:Sheltering Arms Honors Walt "Clyde" Frazier and Cravath, Swaine & Moore LLP at Annual Gala 2Health News:Buckeye Health Plan Announces New Chief Executive Officer 2Health News:Buckeye Health Plan Announces New Chief Executive Officer 3Health News:Innovations with Ed Begley, Jr. to Explore NovaSom, Inc., in Upcoming Episode 2
... holiday season, MINNEAPOLIS, Sept. 8 Courage ... new 2008 Courage Cards fine,art holiday greeting card ... anniversary as a holiday card company!, We ... artists:, Bonnie Bahr-Schneider, Wisconsin Rapids, Wis. -- ...
... ANGELES, Sept. 8 Terrell Samuels, CEO of ... newest physician to their,exclusive roster ... fertility specialist ... Hills. Dr. Saadat is a well-respected fertility,specialist in ... excited about the,opportunities to come. In addition they ...
... brain shrinkage, study shows , , MONDAY, Sept. 8 (HealthDay News) ... to be at increased risk of having brain atrophy or ... Alzheimer,s disease and impaired cognitive function. , Although the study, ... can,t confirm that lower levels of B12 actually cause ...
... IKKalpha (IKKα) regulates the cell cycle of keratinocytes and ... cells from becoming malignant, researchers at The University of ... Sept. 9 issue of Cancer Cell. , "We have ... when necessary, halting proliferation of these important cells. In ...
... that drives consumer choices , , MONDAY, Sept. 8 (HealthDay News) ... when using credit cards, gift cards or gift certificates, according ... the September issue of the Journal of Experimental Psychology: ... have to estimate expenses in detail. , "The more ...
... online toolkit to help,health plans reduce racial and ... 8 The National Health Plan,Collaborative has released ... videos to help health plans identify and reduce ... 11 major health insurance plans, in,partnership with organizations ...
Cached Medicine News:Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 2Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 3Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 4Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 5Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 6Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 7Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 8Health News:Vitamin B12 Key to Aging Brain 2Health News:Vitamin B12 Key to Aging Brain 3Health News:Protein 'switch' suppresses skin cancer development 2Health News:Protein 'switch' suppresses skin cancer development 3Health News:Buyers Spend More With Non-Cash Purchases 2Health News:National Health Plan Collaborative Launches Online Toolkit to Assist Health Plans in Reducing Disparities 2
(Date:5/5/2015)... 2015 Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ... million for the three months ended March 31, 2015 ... $22.6 million for the same period in 2014.  Isis, ... from milestone payments earned from its partners compared to ... Isis reported a loss from operations of $9.3 million ...
(Date:5/5/2015)... PORTLAND, Oregon , May 5, 2015 ... market in the US, Europe , ( ... , Spain , UK) and ... and etiology are reviewed. The report provides the 5-year test volume ... Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, ...
(Date:5/5/2015)... May 5, 2015  Image Stream Medical, a leader ... with MedAssets, one of the largest group purchasing organizations, ... States.  Under terms of the three-year agreement, Image Stream,s ... will be made available to MedAssets members beginning on ... Image Stream Medical CEO Eddie Mitchell said, ...
Breaking Medicine Technology:Isis Reports Financial Results and Highlights for First Quarter 2015 2Isis Reports Financial Results and Highlights for First Quarter 2015 3Isis Reports Financial Results and Highlights for First Quarter 2015 4Isis Reports Financial Results and Highlights for First Quarter 2015 5Isis Reports Financial Results and Highlights for First Quarter 2015 6Isis Reports Financial Results and Highlights for First Quarter 2015 7Isis Reports Financial Results and Highlights for First Quarter 2015 8Isis Reports Financial Results and Highlights for First Quarter 2015 9Isis Reports Financial Results and Highlights for First Quarter 2015 10Isis Reports Financial Results and Highlights for First Quarter 2015 11Isis Reports Financial Results and Highlights for First Quarter 2015 12Isis Reports Financial Results and Highlights for First Quarter 2015 132015 Opportunities in the Global Hepatitis Diagnostic Testing Market: Big Market Research 22015 Opportunities in the Global Hepatitis Diagnostic Testing Market: Big Market Research 3Image Stream Medical Announces Agreement with MedAssets 2
... Conn., Mar. 14, 2011 Biodel Inc. (Nasdaq: ... two new formulations of recombinant human insulin for clinical ... mealtime insulin drug candidates.  The new formulations, BIOD-105 and ... action compared to currently marketed meal time insulin analogs ...
... Inovio Pharmaceuticals, Inc. (NYSE Amex: INO ), ... vaccines against cancers and infectious diseases, announced today that ... initiated a Phase IIb clinical study of its ChronVac-C® ... Inovio,s proprietary electroporation DNA vaccine delivery technology, in combination ...
Cached Medicine Technology:Biodel Announces Accelerated Development Plan for Ultra-Rapid-Acting Insulins: Initiate Phase 2 in 2011; Phase 3 Pivotal Trials in 2012 2Biodel Announces Accelerated Development Plan for Ultra-Rapid-Acting Insulins: Initiate Phase 2 in 2011; Phase 3 Pivotal Trials in 2012 3Biodel Announces Accelerated Development Plan for Ultra-Rapid-Acting Insulins: Initiate Phase 2 in 2011; Phase 3 Pivotal Trials in 2012 4Biodel Announces Accelerated Development Plan for Ultra-Rapid-Acting Insulins: Initiate Phase 2 in 2011; Phase 3 Pivotal Trials in 2012 5Inovio Pharmaceuticals' Partner ChronTech Initiates Phase II Clinical Trial of Hepatitis C Virus DNA Vaccine Using Inovio's Electroporation Delivery Technology 2Inovio Pharmaceuticals' Partner ChronTech Initiates Phase II Clinical Trial of Hepatitis C Virus DNA Vaccine Using Inovio's Electroporation Delivery Technology 3Inovio Pharmaceuticals' Partner ChronTech Initiates Phase II Clinical Trial of Hepatitis C Virus DNA Vaccine Using Inovio's Electroporation Delivery Technology 4Inovio Pharmaceuticals' Partner ChronTech Initiates Phase II Clinical Trial of Hepatitis C Virus DNA Vaccine Using Inovio's Electroporation Delivery Technology 5
... skin over extended wearing time ... barrier is the barrier of ... Security and confidence assured with ... drain valve that allows regulation ...
Inquire...
Inquire...
Protects the skin over extended wearing time from irritating discharge. Flextend skin barrier is the barrier of choice for urostomies and ileostomies with the added benefit of it being discreet in bo...
Medicine Products: